Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease

Pathology International

Volumn 67, Issue 4, 2017, Pages 185-193

  Takahashi, Reisuke H ^a   Nagao, Toshitaka ^a   Gouras, Gunnar K ^b  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Alzheimer's disease; intraneuronal accumulation; multivesicular body; synapse; amyloid

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 2; MICROTUBULE PROTEIN; OLIGOMER; TAU PROTEIN;

ALZHEIMER DISEASE; AMYLOID PLAQUE; BRAIN NERVE CELL; CELLULAR DISTRIBUTION; EARLY DIAGNOSIS; EXTRACELLULAR SPACE; FLUORESCENCE MICROSCOPY; HUMAN; IMMUNOELECTRON MICROSCOPY; INTRACELLULAR SPACE; MOLECULAR PATHOLOGY; MULTIVESICULAR BODY; NERVE DEGENERATION; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; TREATMENT PLANNING; ANIMAL; BRAIN; METABOLISM; NERVE CELL; NEUROFIBRILLARY TANGLE; PATHOLOGY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN; HUMANS; NEUROFIBRILLARY TANGLES; NEURONS;

EID: 85014573134     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/pin.12520     Document Type: Review

References (59)

1. Tang Q, Song PP, Xu LZ. The Government's role in regulating, coordinating, and standardizing the response to Alzheimer's disease: Anticipated international cooperation in the area of intractable and rare diseases. Intractable Rare Dis Res 2016; 5: 238–43.
2. Bonfiglio F. Concerning special findings in a case of probable cerebral syphilis. In: Bick K, Amaducci L, Pepeu G, eds. The Early Story of Alzheimer's Disease. Padova: Liviana Press, 1987; 19–32.
3. Fischer O. Miliary necrosis with nodular proliferation of neurofibrils, a common change of the cerebral cortex in senile dementia. In: Bick K, Amaducci L, Pepeu G, editors. The Early Story of Alzheimer's Disease. Padova: Liviana Press 1987; 5–19.
4. Gouras GK, Almeida CG, Takahashi RH. Intraneuronal Aβ accumulation and origin of plaques in Alzheimer's disease. Neurobiol Aging 2005; 26: 1235–44.
5. Davies CA, Mann DM, Sumpter PQ et al. A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease. J Neurol Sci 1987; 78: 151–64.
6. DeKosky ST, Scheff SW. Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity. Ann Neurol 1990; 27: 457–64.
7. Terry RD, Masliah E, Salmon DP et al. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991; 30: 572–80.
8. Selkoe DJ. The genetics and molecular pathology of Alzheimer's disease: Roles of amyloid and the presenilins. Neurol Clin 2000; 18: 903–22.
9. Walsh DM, Selkoe DJ. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 2004; 44: 181–93.
10. Baker-Nigh A, Vahedi S, Davis EG et al. Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease. Brain 2015; 138: 1722–37.
11. Dafnis I, Argyri L, Sagnou M et al. The ability of apolipoprotein E fragments to promote intraneuronal accumulation of amyloid beta peptide 42 is both isoform and size-specific. Sci Rep 2016; 6: 30654.
12. Gouras GK, Tsai J, Naslund J et al. Intraneuronal Aβ42 accumulation in human brain. Am J Pathol 2000; 156: 15–20.
13. Oddo S, Caccamo A, Shepherd JD et al. Triple-Transgenic model of Alzheimer's disease with plaques and tangles: Intracellular Aβ and synaptic dysfunction. Neuron 2003; 39: 409–21.
14. Takahashi RH, Milner TA, Li F et al. Intraneuronal Alzheimer Aβ42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am J Pathol 2002; 161: 1869–79.
15. Glenner GG, Wong CW. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Comm 1984; 120: 885–90.
16. Kang J, Lemaire H-G, Unterbeck A et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987; 325: 733–6.
17. Haass C, Schlossmacher MG, Hung AY et al. Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 1992; 359: 322–5.
18. Goate AM, Haynes AR, Owen MJ et al. Predisposing locus for Alzheimer's disease on chromosome 21. Lancet 1989; 1: 352–5.
19. Pike CJ, Burdick D, Walencewicz AJ et al. Neurodegeneration induced by β-amyloid peptides in vitro: The role of peptide assembly state. J Neurosci 1993; 13: 1676–87.
20. McLean CA, Cherny RA, Fraser FW et al. Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol 1999; 46: 860–66.
21. Sakono M, Zako T. Amyloid oligomers: Formation and toxicity of Aβ oligomers. FEBS J 2010; 277: 1348–58.
22. Hartmann T. Intracellular biology of Alzheimer's disease amyloid beta peptide. Eur Arch Psychiatry Clin Neurosci 1999; 249: 291–8.
23. Wilson CA, Doms RW, Lee VM. Intracellular APP processing and Aβ production in Alzheimer disease. J Neuropathol Exp Neurol 1999; 58: 787–94.
24. Wertkin AM, Turner RS, Pleasure SJ et al. Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular β-amyloid or A4 peptides. Proc Natl Acad Sci USA 1993; 90: 9513–7.
25. Skovronsky DM, Doms RW, Lee VM. Detection of a novel intraneuronal pool of insoluble amyloid β protein that accumulates with time in culture. J Cell Biol 1998; 141: 1031–9.
26. Hartmann T, Bieger SC, Bruhl B et al. Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides. Nat Med 1997; 3: 1016–20.
27. Xu H, Sweeney D, Wang R et al. Generation of Alzheimer β-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation. Proc Natl Acad Sci USA 1997; 94: 3748–52.
28. Pacheco-Quinto J, Eckman EA. Endothelin-converting enzymes degrade intracellular β-amyloid produced within the endosomal/lysosomal pathway and autophagosomes. J Biol Chem 2013; 288: 5606–15.
29. Cook DG, Forman MS, Sung JC et al. Alzheimer's Aβ (1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells. Nat Med 1997; 3: 1021–3.
30. Koo EH, Squazzo SL. Evidence that production and release of amyloid β-protein involves the endocytic pathway. J Biol Chem 1994; 269: 17386–9.
31. Prelli F, Castano E, Glenner GG et al. Differences between vascular and plaque core amyloid in Alzheimer's disease. J Neurochem 1988; 51: 648–51.
32. Takashashi RH, Sawa H, Kuroda S et al. Pathologic processes leading to cerebral hemorrhage in amyloid angiopathy. Neuropathology 1996; 16: 99–105.
33. Kai H, Shin RW, Ogino K et al. Enhanced antigen retrieval of amyloid β immunohistochemistry: Re-evaluation of amyloid β pathology in Alzheimer disease and its mouse model. J Histoch Cytochem 2012; 60: 761–9.
34. Christensen DZ, Bayer TA, Wirths O. Formic acid is essential for immunohistochemical detection of aggregated intraneuronal Aβ peptides in mouse models of Alzheimer's disease. Brain Res 2009; 1301: 116–25.
35. D'Andrea MR, Reiser PA, Polkovitch DA et al. The use of formic acid to embellish amyloid plaque detection in Alzheimer's disease tissues misguides key observations. Neurosci Lett 2003; 342: 114–8.
36. Almeida CG, Takahashi RH, Gouras GK. β-amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system. J Neurosci 2006; 26: 4277–88.
37. Gruenberg J, Stenmark H. The biogenesis of multivesicular endosomes. Nat Rev Mol Cell Biol 2004; 5: 317–23.
38. Piper RC, Katzmann DJ. Biogenesis and function of multivesicular bodies. Annu Rev Cell Dev Biol 2007; 23: 519–47.
39. Parton RG, Dotti CG. Cell biology of neuronal endocytosis. J Neurosci Res 1993; 36: 1–9.
40. Friedrich RP, Tepper K, Ronicke R et al. Mechanism of amyloid plaque formation suggests an intracellular basis of Aβ pathogenicity. Proc Natl Acad Sci USA 2010; 107: 1942–7.
41. Cataldo AM, Petanceska S, Terio NB et al. Abeta localization in abnormal endosomes: Association with earliest Aβ elevations in AD and Down syndrome. Neurobiol Aging 2004; 25: 1263–72.
42. Zheng H, Jiang M, Trumbauer ME et al. β-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell 1995; 81: 525–31.
43. Umeda T, Tomiyama T, Sakama N et al. Intraneuronal amyloid β oligomers cause cell death via endoplasmic reticulum stress, endosomal/lysosomal leakage, and mitochondrial dysfunction in vivo. J Neurosci Res 2011; 89: 1031–42.
44. Takahashi RH, Almeida CG, Kearney PF et al. Oligomerization of Alzheimer's β-amyloid within processes and synapses of cultured neurons and brain. J Neurosci 2004; 24: 3592–9.
45. Meyer-Luehmann M, Spires-Jones TL, Prada C et al. Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer's disease. Nature 2008; 451: 720–24.
46. Blanchard V, Moussaoui S, Czech C et al. Time sequence of maturation of dystrophic neurites associated with Aβ deposits in APP/PS1 transgenic mice. Exp Neurol 2003; 184: 247–63.
47. Takahashi RH, Capetillo-Zarate E, Lin MT et al. Co-occurrence of Alzheimer's disease β-amyloid and tau pathologies at synapses. Neurobiol Aging 2010; 31: 1145–52.
48. Lewis J, Dickson DW, Lin W-L et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 2001; 293: 1487–91.
49. Gotz J, Chen F, van Dorpe J et al. Formation of neurofibrillary tangles in P301L tau transgenic mice induced by Aβ42 fibrils. Science 2001; 293: 1491–5.
50. Gyure KA, Durham R, Stewart WF et al. Intraneuronal Aβ-amyloid precedes development of amyloid plaques in Down syndrome. Arch Pathol Lab Med 2001; 125: 489–92.
51. Iqbal K, Liu F, Gong C-X et al. Mechanisms of tau-induced neurodegeneration. Acta Neuropathol 2009; 118: 53–69.
52. Capetillo-Zarate E, Gracia L, Yu F et al. High-resolution 3D reconstruction reveals intra-synaptic amyloid fibrils. Am J Pathol 2011; 179: 2551–8.
53. Takahashi RH, Capetillo-Zarate E, Lin MT et al. Accumulation of intraneuronal β-Amyloid 42 peptides is associated with early changes in microtubule-associated protein 2 in neurites and synapses. PLoS One 2013; 8: e51965.
54. Capetillo-Zarate E, Staufenbiel M, Abramowski D et al. Selective vulnerability of different types of commissural neurons for amyloid β-protein-induced neurodegeneration in APP23 mice correlates with dendritic tree morphology. Brain 2006; 129: 2992–3005.
55. Moolman DL, Vitolo OV, Vonsattel JP et al. Dendrite and dendritic spine alterations in Alzheimer models. J Neurocytol 2004; 33: 377–87.
56. Wu CC, Chawla F, Games D et al. Selective vulnerability of dentate granule cells prior to amyloid deposition in PDAPP mice: Digital morphometric analyses. Proc Natl Acad Sci USA 2004; 101: 7141–6.
57. Bahr BA, Hoffman KB, Yang AJ et al. Amyloid β protein is internalized selectively by hippocampal field CA1 and causes neurons to accumulate amyloidogenic carboxyterminal fragments of the amyloid precursor protein. J Comp Neurol 1998; 397: 139–47.
58. Meyer-Luehmann M, Coomaraswamy J, Bolmont T et al. Exogenous induction of cerebral β-amyloidogenesis is governed by agent and host. Science 2006; 313: 1781–4.
59. Karch CM, Cruchaga C, Goate AM. Alzheimer's disease genetics: From the bench to the clinic. Neuron 2014; 83: 11–26.